SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-23-010678
Filing Date
2023-03-08
Accepted
2023-03-08 16:00:17
Documents
2
Group Members
INTERMEDIATE CAPITAL INVESTMENTS LTD

Document Format Files

Seq Description Document Type Size
1 SC13G/A brhc10049483_sc13ga.htm SC 13G/A 105549
2 EXHIBIT 99.1 brhc10049483_ex99-1.htm EX-99.1 5083
  Complete submission text file 0001140361-23-010678.txt   112259
Mailing Address JUXON HOUSE 100 ST. PAUL'S CHURCHYARD LONDON X0 EC4M 8BU
Business Address JUXON HOUSE 100 ST. PAUL'S CHURCHYARD LONDON X0 EC4M 8BU 0044 203 201 7700
Intermediate Capital Group plc (Filed by) CIK: 0001705162 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0331
Type: SC 13G/A

Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 425-276-2300
Eliem Therapeutics, Inc. (Subject) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92797 | Film No.: 23716073
SIC: 2834 Pharmaceutical Preparations